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The hematopoietic system offers many advantages as a model for
understanding general aspects of lineage choice and specification.
Using oligonucleotide microarrays, we compared gene expression
patterns of multiple purified hematopoietic cell populations, in-
cluding neutrophils, monocytes, macrophages, resting, centrocytic,
and centroblastic B lymphocytes, dendritic cells, and hematopoietic
stem cells. Some of these cells were studied under both resting and
stimulated conditions. We studied the collective behavior of sub-
sets of genes derived from the Biocarta database of functional
pathways, hand-tuned groupings of genes into broad functional
categories based on the Gene Ontology database, and the meta-
bolic pathways in the Kyoto Encyclopedia of Genes and Genomes
database. Principal component analysis revealed strikingly perva-
sive differences in relative levels of gene expression among cell
lineages that involve most of the subsets examined. These results
indicate that many processes in these cells behave differently in
different lineages. Much of the variation among lineages was
captured by the first few principal components. Principal compo-
nents biplots were found to provide a convenient visual display of
the contributions of the various genes within the subsets in lineage
discrimination. Moreover, by applying tree-constructing method-
ologies borrowed from phylogenetics to the expression data from
differentiated cells and stem cells, we reconstructed a tree of
relationships that resembled the established hematopoietic pro-
gram of lineage development. Thus, the mRNA expression data
implicitly contained information about developmental relation-
ships among cell types.
The hematopoietic system contains cells of more than a dozenmature types, derived from a single stem cell. Individual
lineages and their dedicated precursor cells are stably deter-
mined and resistant to a variety of changes in the milieu of a cell
or exhibit a narrow range of developmental choices that are
selected through some combination of stochastic and instructive
processes under precise conditions (1, 2). Instead of focusing on
a many individual, unrelated, differentially expressed genes, we
sought to investigate the differences among multiple hemato-
poietic cell types from a global viewpoint.
To study the transcriptome composition of hematopoietic
cells, one could apply standard methods to identify single genes
that are expressed at levels that are different for each lineage.
This approach is limited in explaining the overall differences
among lineages because we did not find even a small number of
individual genes whose expression levels distinguished among all
cell types, although there are many genes that significantly
differentiate between two or more cell types.
Another analytical approach toward the goal of learning about
how the cell types differ in gene expression would be to search
in our data for a set of genes, together with a particular
discriminant function of the expression levels of those genes that
optimally distinguishes the cell types. Such a ‘‘supervised learn-
ing’’ approach is common in pattern recognition problems in
which a large number of examples of patterns from the different
classes are given (3, 4). In our case, we have thousands of
variables (genes) to use in discriminating among the types
of cells, but for each type, we have only a very small number of
examples of that type. In a case like this, ‘‘overfitting’’ in pattern
recognition becomes a particularly serious concern; we can
always find many functions that discriminate among sets of a
handful of points in a space of thousands of dimensions, but then
we would have little confidence that we have learned anything
real that would generalize beyond the few given data points.
To avoid this problem, we investigated whether an unsuper-
vised approach to dimension reduction would also lead to
discrimination among the cell types. Because we do not make use
of information about the cell types in reducing the data to a few
dimensions, worries about overfitting are ameliorated. When we
project the data onto two dimensions by using principal com-
ponents and then see that the different cell types project onto
different regions of the plane (as in Figs. 1 and 2), we can trust
that the discrimination we are witnessing is genuine. Because the
projection used no information about the identities of the cell
types, we know we have not overfit the data; indeed the
projection is simply a view of the data without ‘‘fitting’’ the
cell-type labels at all.
Reduction in the number of variables could have been
achieved by representing gene clusters obtained in an unsuper-
vised clustering analysis by their leading principal components
(5). However, our analysis was constructed to represent the
system by using variables that are directly related to biological
processes (or functions), which would allow us to investigate
differences and similarities in activity of each of these processes
among the cell types.
We attempted to identify functional categories of genes whose
expression levels vary between the different lineages more
extensively than within any single lineage, but we found that a
large number of broadly expressed genes have relative levels of
expression that distinguish among various types of cells. A
similar distinction is also apparent in the expression levels of
genes limited to specific metabolic pathways. Lineage-specific
patterns of expression were seen even with ‘‘housekeeping’’
genes that are expressed very broadly in experiments reported in
the literature. Most individual genes show significant lineage-
specific differences in their relative levels of expression, and each
lineage is characterized by a pervasive distinct pattern of gene
expression. However, these patterns are constrained such that
the first few principal components account for a large part of the
variation. The gene expression data also contain information
about the developmental histories of these cells, as shown by a
tree resembling the standard hematopoietic program that we
constructed by usingmethodology borrowed from phylogenetics.
Materials and Methods
Cell Isolation, RNA Extraction, and Probe Preparation. The methods
for preparation and treatment of individual cell types are
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indicated in the legend of Fig. 1. RNA from each cell type was
extracted most often by use of commercial kits (RNeasy, Qiagen,
Valencia, CA), except for neutrophils, from which total RNA
was extracted by a guanidineHCl method, as described (6, 7).
RNA quality was evaluated by measuring the ratio of 28S to 18S
rRNA on agarose gel electrophoresis and by determining the
ratio of optical absorbance at 260 and 280 nm. Samples were
rejected if the A280:A260 or the 18S:28S rRNA ratio was 0.6 or
if samples showed any traces of degradation or DNA contami-
nation on gel electrophoresis. In general, samples were rejected
if10 mg of total RNA was obtained from a single preparation.
Each preparation was from a single patient, and for the most
part, replicate samples of the same cell type were from different
donors. RNA analysis was performed on the Affymetrix
HGU133 chip set (Santa Clara, CA), using standard techniques
for probe preparation and the Affymetrix MAS 5.0 normalization
procedure. The human cell population was derived from periph-
eral blood stem cells from a healthy donor mobilized by gran-
ulocyte colony-stimulating factor (G-CSF) (8). We used a two-
step positive–negative selection technique in which CD34 cells
are isolated and then depleted of CD38 by using immunimag-
netic beads. The resultant population was 93% CD34 and had
1% CD38 cells.
In the present work, we have included only one stem cell
sample because of the expense of obtaining enough human cells
of this type to perform RNA analysis without previous ampli-
fication and, therefore, to keep the results strictly comparable to
those from the other samples. However, we have data from a
second human stem cell preparation analyzed with an earlier
version of the oligonucleotide chip (Affymetrix HGU95) that
gave similar results (data not shown).
Simultaneous Array and Gene Normalization. Recently (39) we
developed a normalization procedure based on the concept that
two genes (and likewise two samples) whose expression profiles
differ only by a multiplicative constant of proportionality are
really behaving in the same way. After taking logarithms of each
element in the data matrix, we considered two genes (each
represented by a row of the matrix) or two samples (represented
by the columns of the matrix) to be equivalent if their expression
profiles differ by an additive constant. The resulting normaliza-
tion, which involves taking logarithms of the entries in the data
matrix followed by subtraction of the row and column means and
addition of the overall mean at each entry, can be thought as a
two-way ANOVA-like procedure, which removes first-order
effects and extracts the desired gene–sample interaction effects.
Previously (39) this choice of normalization led to better sepa-
ration between distinct cell types.
Filtering. Before further analysis, we discarded the genes labeled
by the Affymetrix MAS software as absent in all samples. This
procedure maximizes the number of remaining genes so that the
collective expression profiles we derive for each pathway will
have a sufficient number of representative genes. Alternatively,
we used filtering in which we kept only genes that were flagged
as present in every sample by the Affymetrix software.
Principal Component Analysis (PCA). Our dataset is tabulated in a
matrix consisting of tens of thousands of genes (rows) and 92
samples (columns) that span 27 different cell types. The number
of samples is two orders of magnitude smaller than the number
of variables (genes). Reduction in the number of variables is
useful for visualizing major trends and structure inherent in the
data. PCA is an unsupervised dimension reduction method that
generates a new set of decorrelated variables (principal compo-
nents) as linear combinations of the original variables (genes).
For an introductory explanation see www.statsoftinc.com
textbookstfacan.html. The majority of the variation of microar-
ray datasets (samples) can be captured by the most dominant
principal components. An additional advantage of expressing
the data in terms of the leading principal components is their
robustness to noise. The projections of the samples onto the
leading principal components are computed by applying the
singular value decomposition to the data matrix (after prepro-
cessing as described above).
Data Balancing. The number of replicate samples in our data
repository of 27 cell types varies from 1 (for the hematopoietic
stem cell) to 18 (for the monocytes). This imbalance should be
taken into account before performing PCA. We did this by
forming a matrix for each cell type containing 18 columns. For
cell types with 18 measurements, we replicated existing mea-
surements. When 18 was not exactly divisible by the number of
measurements, we added columns with median expression levels
across the existing samples of the particular cell type. For
example, we had four samples of macrophages; therefore we
concatenated their median profile twice together with four
replicates of each sample. The resulting balanced data matrix
contained 18  26 columns.
Biplot. We used principal component biplots to display the
expression profiles of the genes (rows of the data matrix) and the
cell types (columns of the data matrix) simultaneously as points
in 2D space (40). The biplot provides an optimal approximation
of the data matrix by such a 2D structure, in the sense that it
displays the singular value decomposition, which gives the rank-
two approximation to the data matrix having the smallest
mean-squared error. The expression of a given gene in a given
sample is approximated by the projection of the gene vector onto
the direction of the sample vector, multiplied by the length of the
sample vector. Thus, in this rank-two approximation, for a given
gene and for sample vectors of a given length, the gene is
expressed at a higher (or lower) level in samples whose vector
points in nearly the same (or opposite) direction as the gene. A
gene is not differentially expressed between samples that are
located on a line orthogonal to the gene vector.
Linear Discriminant Analysis. One of our primary methods for
visualizing data corresponding to a given subset of genes was to
project the data onto the first two principal component direc-
tions and then inspect the resulting 2D scatter plot to see how
well the various cell types were separated. We used linear
discriminant analysis and cross validation to construct a descrip-
tive statistic to quantify the extent to which the cell type groups
are separated in a given projection. The starting point is a scatter
plot containing, for each of the n samples in the data set, the 2D
coordinates for that sample together with the corresponding
class label, i.e., the cell type of that sample. For each of the n
samples in turn, we would remove that sample from the data, find
the optimal linear discriminant boundaries for the resulting data
set of n  1 samples, and then check whether the resulting
discriminant boundaries correctly classify the held-out data
point. (This procedure was carried out by using the function
‘‘lda’’ from the MASS library of the statistical computing
package R.) We took the fraction of samples that were classified
correctly after being left out of the data in this way as a measure
of how well the classes were separated in the 2D projection. This
measure is used in Fig. 3.
Phylogenetic Analysis. In typical phylogenetic studies, the goal is
to recover the tree that represents the evolutionary history of
species by using a collection of biological sequences. Instead of
different species of organisms, our taxa are the different cell
types in our study. Our data are also not typical for current
phylogenetic studies because we are using gene expression
measurements potentially taking a continuum of values, rather














than sequences chosen from a small alphabet such as nucleotides
or amino acids.
The class of phylogenetic methods that seemed most straight-
forward to adapt to our problem are the distance-basedmethods,
such as neighbor joining and the unweighted pair group method
using arithmetic averages (UPGMA), which take as their input
a matrix of estimated distances between pairs of taxa. Applying
these methods to our data requires us to choose a method of
calculating a distance between two gene expression profiles. The
most important property desired for a measure of distance in this
context is that it be additive, or nearly additive, in the following
sense. A distance measure is additive on a tree if the distance
between any pair of observed taxa is the sum of the lengths of
all branches on the path joining those two species in the tree,
where each branch length is the result of applying the same
distance measure to the (possibly unobserved and hypothetical)
taxa at the two ends of the branch. Consideration of the
stochastic processes by which the measured characteristics
change as the tree is traversed can suggest additive distance
measures, e.g., Markov process models have led to various
measures of distance in standard phylogenetic studies (41, 42).
In our problem, as a first rough model, we could postulate that
the logarithms of the gene expression values change according to
a random-walk-like process in development. After a bifurcation
at which one lineage splits into two, the two resulting lineages
would be imagined to develop independently. Because the
variance is additive for independent random variables, the
requirement of additivity in such a model suggested that we use
the variance of the differences in logarithm of gene expression
values as our distance measure.
Results
Pathway Analysis. To study cell type specificity of various biolog-
ical processes, we computed the leading principal components
for each of the pathways annotated in Biocarta or the Kyoto
Encyclopedia of Genes and Genomes (KEGG), or for function-
ally defined families of genes obtained from Gene Ontology.
Each such set of principal components gives a low-dimensional
summary of the expression measurements for the corresponding
set of genes. More specifically, the complete expression infor-
mation of any given pathway is stored in a matrix whose rows
represent the genes of this pathway and whose columns represent
the multiple samples from the various cell types. This informa-
tion can be represented more simply by computing a relatively
small number of specific linear combinations of the gene profiles
of the pathway. The coefficients in the linear combination are
principal component directions. For a given pathway, the ex-
pression profiles of the samples (cell types) are summarized by
their projections onto a small number of principal components
directions. For many pathways, the projection of the expression
profiles of the samples onto two principal component directions
reveals clear separation between the different cell types that is
not observed by inspecting the expression patterns of individual
genes. Studying the system in terms of a few hundred collective
variables representing biologically defined pathways, instead of
tens of thousands of variables corresponding to individual genes,
allows us to have a more coarse-grained global picture of the cell
type characteristics.
As primary data, we used expression analyses of 92 samples
representing the 27 cell types detailed in Fig. 1. To examine the
differences in pathways and functional activities among these 27
cell types, we performed a PCA of gene expression data nor-
malized as described in Materials and Methods, to determine
whether well separated cell type clusters could be identified. We
projected the multidimensional data onto a 2D space spanned by
the two leading principal components, represented by the two
axes of the graph.
A major regulator of the pattern of gene transcription in any
cell is the abundance and activity of protein complexes including
the sequence specific factors that interact with DNA. We
Fig. 1. (A) PCA and biplot. Shown is the projection of 92 samples collected from 27 cell types onto the two leading principal components of a submatrix
consisting of expression profiles of 93 transcription factors present in all samples. Clustering of samples is evident, even though the identities of the samples were
not used in performing the projection. Before PCA the genome-wide data matrix was preprocessed by taking the logarithm of each entry in the matrix followed
by subtraction of the row and column means of this entry and addition of the overall mean, leading to a normalized matrix having all row sums and all column
sums equal to zero. Each cell type is represented by a distinct symbol (numbers of samples are in brackets and method of preparation is referenced). Overlaying
a 2D scatter plot, representing the contribution of the genes (represented by dots) to the first and second principal components on top of the 2D sample scatter
plot, forms a biplot. An inner product between a gene and a sample (which is equal to the product of the length of a vector pointing from the origin to the sample,
the length of a vector pointing from the origin to the gene, and the cosine between these vectors) approximates the normalized expression value of the gene
at this sample. The accumulated variation captured by the first and second principal components is 60% of the total variation. (B) A biplot for the KEGG galactose
metabolism pathway. This biplot represents samples as in A for 26 genes from the galactose metabolism pathway, which was expressed in at least one sample.
The HK3 and MGAM genes were located out of the frame; therefore the true location is indicated in parentheses. The biplot can be used to read approximated
normalized expression levels. For example, normalized expression levels of HK3 are elevated in the monocyte samples in comparison with the B cell samples.
Similarly, expression levels of MGAM are highly elevated in neutrophils in comparison with the rest of the cells. The accumulated variation captured by the first
and second principal components is 74%.
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therefore initially studied the patterns of transcripts for genes
encoding known transcription factors. To investigate the speci-
ficity and stability of lineage-specific gene expression, we in-
cluded expression patterns of several continuous cell lines in-
cluding Epstein–Barr virus-transformed lymphoblasts, T and B
cell lymphomas, and control melanocyte cultures. We used Gene
Ontology to select genes related to transcriptional activity. The
list from Gene Ontology was curated by hand to eliminate
obvious misclassifications and add missing components. To aid
in this process, Locus Link was used to collect genes whose
description included relevant terms, and these genes were ex-
amined individually for appropriateness. In addition, the tran-
scriptional activity list was curated to remove subunits of core
polymerases, general transcriptional components, and elonga-
tion or termination factors.
We derived principal components by using either all of the
genes that were found to be present in at least one sample or,
more stringently, only those genes listed as present in every
sample. As shown in the scatter plot in Fig. 1a, even in the latter
case most of the samples of the different cell types are separable.
The projection of the samples onto the first principal component
explains 46% of the variability of the data and is sufficient for
partitioning the major groups of lineages. Moreover, the second
principal component captures 14% of the data variability. The
transcription factors contributing most to the first two principal
components are labeled on the figure. The factors whose pro-
jection along the first two principal components was largest
include some, such as CEBPB (CCAATenhancer-binding pro-
tein ), that would have been expected to vary in levels between
cell types, based on a number of studies of their role in
lineage-specific gene expression. A number of other factors, such
as HDAC1, a common histone deacetylase, would not a priori
have been predicted to be important in distinguishing among cell
lineages.
These studies were extended to genes related to apoptosis,
translation, receptor activity, cytokine activity, proteolysis, or
protein kinase activity. Broadly speaking, the subsets of genes
fell into two categories. In the case of cytokines and receptors,
most of the genes that were present in some samples were not
detected in other samples. In these cases, a large number of genes
were listed as present in at least one sample, and classification
of lineages by using all these genes gave a clear separation
according to lineage by use of the first two principal components.
On the other hand, if only genes listed as present in all samples
were included, very few genes were left, and the separation of
lineages by using these genes was incomplete. For other gene
sets, such as transcription factors or proteolytic genes, the
number of genes whose expression was detected in all samples
was relatively high, with correspondingly good lineage separa-
tion by the first principal components. Generally, the first two
principal components accounted for a major fraction of the total
variation of samples and revealed extensive separation between
cell lineages.
The KEGG and Biocarta databases present catalogs of groups
of genes, classified according to their linkage in known pathways
including those for small molecules. We examined the principal
component analyses for each of the 137 pathways described in
KEGG and the 245 networks listed in Biocarta. The number of
genes per pathway varies, and this variation contributes to the
ability of each gene set to separate lineages. However some small
pathways clearly had greater power to separate lineages. As an
example of lineage discrimination by a KEGG pathway, Fig. 1b
shows the separation of lineages obtained by use of the first two
principal components from the galactose pathway, together with
the genes listed for the pathway. The bias in expression of
MGAM (-glucosidase), and HK3 (hexokinase 3) is particularly
striking. The physiology underlying this bias is not immediately
evident, although one might speculate, for example, about
effects on innate immunity of the membrane-associated gluco-
sidase in removing terminal glucose residues from cell surface
complex carbohydrates. These initial results show that, without
supervision, the data clearly separated samples according to the
lineage of cells from which they were derived.
Because most subsets of genes seemed to give good lineage
separation, we then asked whether a less discriminating set of
housekeeping genes could be identified as a subset of genes
expressed commonly in all lineages. To do this, we used data
reported for genes whose expression had been detected in each
of 47 types of cells or tissues reported at various times in the
literature (9). As shown in Fig. 2, of 580 of the housekeeping
genes listed in the literature, only 260 were recorded as expressed
in all of our experiments. When either the 580 or the 260 genes
in this group were used, the first two principal components again
separated most or all lineages.
Having found that sets of genes that we expected to behave
similarly across the cell lines have the ability to distinguish
lineages, we speculated that even randomly chosen subsets of
genes might exhibit some ability to discriminate the cell types. To
test this conjecture, we applied multiclass linear discriminant
analysis to randomly selected gene subsets of variable size. We
found that for the majority of these subsets, the first and second
principal components were sufficient to predict the cell type with
very good accuracy (Fig. 3). Furthermore, for most pathways
containing more than 20 genes, there was a range of the
number of principal components that led to optimal separation
of the cell types. This result indicates that the differences among
the cell types are distributed among a very large set of genes and
remain consistently evident in sufficiently large randomly chosen
subsets of genes.
Development Tree. We next examined whether cell-type expres-
sion profiles provide sufficient information that may be used to
infer a development tree in the same fashion that DNA se-
quences from different species are used to infer phylogenetic
trees. Fig. 4 illustrates a developmental tree generated by using
the neighbor-joining algorithm (43) together with the a measure
of distance between expression profiles as described inMaterials
and Methods. We note that the stem cell is positioned between
the myeloid and lymphoid lineages. Moreover, the first split in
Fig. 2. PCA as in Fig. 1 but for 580 housekeeping genes reported in the
literature that were expressed in at least one of the 92 samples. (Although the
literature refers to 575 housekeeping genes, a few of the sequences match
more than one gene so that the total number of matching genes is slightly
greater.) The Jurkat cell is an outlier of this set of genes and therefore it was
excluded in this analysis. The accumulated variation captured by the first and
second principal components is 61%.














the lymphoid branch separates the B cells from the T cell sample.
Down the B lymphocyte branch, the next split separates the
resting cells from the centrocytes and centroblasts. The first split
in the myeloid branch separates the neutrophil group and
monocytes from the dendritic cells and macrophages that were
generated by stimulating monocytes. We would expect the
monocytes to branch off from the edge leading to the dendritic
cells and macrophages, instead of the edge leading to the
neutrophils. Aside from this single discrepancy, the topology of
this tree matches our current knowledge of hematopoietic
development. Thus, cell-type expression profiles containing the
expression values of all transcription factors (and other func-
tional groups of genes) are sufficient not only to differentiate
between the cell lineages but also to capture developmental
relationships between these cells. We note that using UPGMA,
an alternative distance-based approach for building trees that
implicitly relies on a molecular clock type of assumption, recon-
structed an incorrect tree.
Discussion
In the present study, we compared expression profiles of a large
number of genes in a number of terminally differentiated cells
that all derive from a common precursor. To examine the
expression data, we used a normalization procedure that set the
geometric mean of expression values of the particular group of
genes to be the same for each sample and also set the geometric
mean of expression values of each separate gene across all
samples to be the same. This process loses some information.
However, the procedure focuses on the differences in patterns of
gene expression within a particular group. Also, the relative
levels of expression of a given gene may more accurately reflect
its contribution to a process in different cell types than does its
absolute level of expression. The high quality of lineage sepa-
rations obtained in this study indicates that, regardless of ratio-
nale, the normalization approach retained important biologic
information.
As expected, the amount of total variation contributed by the
first two principal components decreased as the number of genes
in a group increased. However, it was striking that the first two
principal components contributed a relatively large fraction,
generally more than one-third, of the total variation in almost all
cases. These data indicate considerable structure to the patterns
of variation of lineage-specific expression.
Graphing the position of specific genes on the same principal
component plot as that showing the cell lineages is a convenient
way of visualizing the potential contribution of specific factors to
the separation of the various lineages. The projection of the
vector from the origin to the factor onto the vector pointing to
each lineage is an estimate of the contribution of that factor to
the specificity of that lineage. It is noteworthy that most vectors
for individual genes were not parallel to the vector for any
lineage, consistent with the expectation that most factors are
used in different relative amounts and in a combinatorial fashion
to specify lineages.
Describing the cells in terms of principal component variables
summarizing the collective behavior of genes in various pathways
may be a suitable framework for studying statistical relationships
among the pathways. For example, one can inspect the level of
correlations between the pathway variables or investigate the
extent to which these variables interact with each other in
multivariate statistical models designed to discriminate between
the various cell types. Identifying strong pathway–pathway sta-
tistical associations is useful for designing experiments to explore
biological inter-relationships among pathways. These collective
variables are expected to be more robust to microarray experi-
mental noise than the individual gene variables and therefore
could be useful for future system biology studies.
One unanticipated result of the present set of analyses was the
pervasiveness of lineage specificity of the relative levels of
expression of genes. The number of products whose level was
relatively constant (1.5-fold variation in median expression)
was so small as to be almost statistically insignificant. To a
greater degree than anticipated, the lineage specificity of dif-
ferential expression of known genes is not readily interpreted, as
shown here for the enzymes in the KEGG galactose metabolism
group. Among other things, this observation suggests the diffi-
culty in predicting cell type-specific effects of pharmacologic
agents or even transcription factors. More generally, the present
approach affords a convenient exploratory tool for investigating
lineage differences among cells with respect to biologically
defined functions and gene subsets.
Fig. 3. Map of error rates as a function of a gene subset sizes. For each subset
size we randomly selected 100 subsets of genes out of the annotated 17,460
genes printed on the U133 Affymetrix chip. We then derived the first and
second principal components for each of these gene subsets. These principal
components were used as predictors in linear discriminant analysis to classify
the different lineages. The vertical axis of the map represents the subset size.
Each subset size has 100 samples sorted along the horizontal axis according
their misclassification error rate. As we increase the subset size, the fraction of
subsets with zero error rate increases. Thus the potential to partition the
samples by using the information stored in the first two principal components
increases as the gene subset size increases.
Fig. 4. Development tree: An unrooted tree with undetermined direction of
time was derived by using the neighbor-joining tree reconstruction algorithm
as implemented in PHYLIP (43). The input distance matrix between the different
cell types was derived by using the variance between the logarithms of the
mean cell-type profiles. The lymphoid and myeloid branches and their sub-
branches are separated in accordance with the established hematopoietic
program.
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The position of the stem cells was often somewhat closer to B
cells than the other lineages, but stem cells occupied a relatively
central position in the principal component projections for
almost all of the gene sets examined. Morphologically, stem cells
resemble lymphocytes, and the genes contributing to this ap-
pearance might be one factor in the positioning of the stem cells.
However, the central position could be due to several more
important factors. Technically, the stem cell population is a very
small subset of cells, and their definition by surface markers is
rather indirect, so that the preparations could be heterogeneous
in ways that are not obvious from fluorescence-activated cell
sorter analysis. Low levels of mRNA for some B cell-specific
genes were present in the stem cell sample, and this result could
represent either contamination or expression of some lineage-
specific genes in true stem cells. The stem cells do express a
somewhat larger number of genes than the cells of the various
differentiated lineages. They take an intermediate position in the
2D space spanned by the first two principal components but have
a projection on the remaining principal components that is larger
than most of the other cell types. Our analyses also suggest that
each lineage specification represents a different perturbation
from a generalized stem cell rather than a progressive addition
of layers of differentiation on some other lineage.
In summary, we have analyzed gene expression in differenti-
ated cells of multiple hematopoietic lineages, experimentally and
mathematically. The results show an impressively pervasive
lineage specificity in gene expression, extending across many
pathways and gene types. The hematopoietic cell types studied
represent terminally differentiated cells, some of which are
postmitotic. This may heighten the differences between lineages.
It will be of considerable interest to extend the analyses across
other well defined cell types and to compare the results
with more undifferentiated cells and cells of nonhematopoietic
lineages.
This work was supported by National Institutes of Health Grant
POL HL 633571.
1. Payne, K. J. & Crooks, G. M. (2002) Immunol. Rev. 187, 48–64.
2. Cantor, A. B. & Orkin, S. H. (2001) Curr. Opin. Genet. Dev. 11, 513–519.
3. Pavlidis, P., Lewis, D. P. & Noble, W. M. (2002) Pacific Symp. Biocomput. 7,
474–485.
4. Mateos, A., Dopazo, J., Jansen, R., Tu, Y., Gerstein, M. & Stolovitzky, G.
(2002) Genome Res. 12, 1703–1715.
5. Huang, E., Cheng, S. H., Dressman, H., Pittman, J., Tsou, M. H., Horng, C. F.,
Bild, A., Iversen, E. S., Liao, M., Chen, C. M., et al. (2003) Lancet 361,
1590–1596.
6. Subrahmanyam, Y. V., Baskaran, N., Newburger, P. E. & Weissman, S. M.
(1999) Methods Enzymol. 303, 272–297.
7. Subrahmanyam, Y. V., Yamaga, S., Prashar, Y., Lee, H. H., Hoe, N. P., Kluger,
Y., Gerstein, M., Goguen, J. D., Newburger, P. E. & Weissman, S. M. (2001)
Blood 97, 2457–2468.
8. Debelak, J., Shlomchik,M. J., Snyder, E. L., Cooper, D., Seropian, S., McGuirk,
J., Smith, B. & Krause, D. S. (2000) Transfusion 40, 1475–1481.
9. Tsukahara, Y., Lian, Z., Zhang, X., Whitney, C., Kluger, Y., Tuck, D., Yamaga,
S., Nakayama, Y., Weissman, S. M. & Newburger, P. E. (2003) J. Cell. Biochem.
89, 848–861.
10. Lian, Z., Wang, L., Yamaga, S., Bonds, W., Beazer-Barclay, Y., Kluger, Y.,
Gerstein, M., Newburger, P. E., Berliner, N. & Weissman, S. M. (2001) Blood
98, 513–524.
11. Lian, Z., Kluger, Y., Greenbaum, D. S., Tuck, D., Gerstein, M., Berliner, N.,
Weissman, S. M. & Newburger, P. E. (2002) Blood 100, 3209–3220.
12. Zhang, X., Kluger, Y., Poddar, R., Whitney, W., DeTora, A., Weissman, S. M.
& Newburger, P. E. (2004) J. Leukocyte Biol. 75, 358–372.
13. Kumagai, K., Itoh, K., Hinuma, S. & Tada, M. (1979) J. Immunol. Methods 29,
17–25.
14. Cathcart, M. K., Morel, D. W. & Chisolm, G. M., III 1985) J. Leukocyte Biol.
38, 341–350.
15. Williams, L. A., Egner, W. & Hart, D. N. (1994) Int. Rev. Cytol. 153, 41–
103.
16. Fearnley, D. B., McLellan, A. D., Mannering, S. I., Hock, B. D. & Hart, D. N.
(1997) Blood 89, 3708–3716.
17. Markowicz, S. & Engleman, E. G. (1990) J. Clin. Invest. 85, 955–961.
18. Sallusto, F. & Lanzavecchia, A. (1994) J. Exp. Med. 179, 1109–1118.
19. Pelchen-Matthews, A., Kramer, B. & Marsh, M. (2003) J. Cell Biol. 162,
443–455.
20. Chalouni, C., Banchereau, J., Vogt, A. B., Pascual, V. & Davoust, J. (2003) Int.
Immunol. 15, 457–466.
21. Sims-Mourtada, J. C., Guzman-Rojas, L., Rangel, R., Nghiem, D. X., Ullrich,
S. E., Guret, C., Cain, K. & Martinez-Valdez, H. (2003) Immunology 110,
296–303.
22. Pascual, V., Liu, Y. J., Magalski, A., de Bouteiller, O., Banchereau, J. & Capra,
J. D. (1994) J. Exp. Med. 180, 329–339.
23. Denepoux, S., Fournier, N., Peronne, C., Banchereau, J. & Lebecque, S. (2000)
J. Immunol. 164, 1306–1313.
24. Poltoratsky, V., Woo, C. J., Tippin, B., Martin, A., Goodman, M. F. & Scharff,
M. D. (2001) Proc. Natl. Acad. Sci. USA 98, 7976–7981.
25. Nakayama, Y., Iwamoto, Y., Maher, S. E., Tanaka, Y. & Bothwell, A. L. (2000)
Biochem. Biophys. Res. Commun. 277, 124–127.
26. Sale, J. E. & Neuberger, M. S. (1998) Immunity 9, 859–869.
27. Papavasiliou, F. N. & Schatz, D. G. (2000) Nature 408, 216–221.
28. Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A., Lane, W. S. &
Strominger, J. L. (1993) J. Exp. Med. 178, 27–47.
29. Arunachalam, B., Pan, M. & Cresswell, P. (1998) J. Immunol. 160, 5797–5806.
30. Schneider, U., Schwenk, H. U. & Bornkamm, G. (1977) Int. J. Cancer 19,
621–626.
31. Brosterhus, H., Brings, S., Leyendeckers, H., Manz, R. A., Miltenyi, S., Radbruch,
A., Assenmacher, M. & Schmitz, J. (1999) Eur. J. Immunol. 29, 4053–4059.
32. Dagna, L., Iellem, A., Biswas, P., Resta, D., Tantardini, F., Fortis, C.,
Sabbadini, M. G., D’Ambrosio, D., Manfredi, A. A. & Ferrarini, M. (2002) Eur.
J. Immunol. 32, 2934–2943.
33. Angelopoulou, M., Novelli, E., Grove, J. E., Rinder, H. M., Civin, C., Cheng,
L. & Krause, D. S. (2003) Exp. Hematol. 31, 413–420.
34. Donnelly, D. S. & Krause, D. S. (2001) Leuk. Lymphoma 40, 221–234.
35. Lozzio, C. B. & Lozzio, B. B. (1975) Blood 45, 321–334.
36. Yee, C., Krishnan-Hewlett, I., Baker, C. C., Schlegel, R. & Howley, P. M.
(1985) Am. J. Pathol. 119, 361–366.
37. Bejar, J., Hong, Y. & Schartl, M. (2003) Development (Cambridge, U.K.) 130,
6545–6553.
38. Bohm, M., Moellmann, G., Cheng, E., Alvarez-Franco, M., Wagner, S.,
Sassone-Corsi, P. & Halaban, R. (1995) Cell Growth Differ. 6, 291–302.
39. Kluger, Y., Basri, R., Chang, J. T. & Gerstein, M. (2003) Genome Res. 13,
703–716.
40. Cox, T. F. & Cox, A. A. (2001) Multidimensional Scaling (Chapman & Hall,
London).
41. Baake, E. & Haeseler, A. V. (1999) Theor. Popul. Biol. 55, 166–175.
42. Chang, J. T. (1996) Math. Biosci. 137, 52–73.
43. Felsenstein, J. (1989) Cladistics 5, 164–166.
Kluger et al. PNAS  April 27, 2004  vol. 101  no. 17  6513
D
EV
EL
O
PM
EN
TA
L
BI
O
LO
G
Y
